Lemtrada Receives FDA Approval for New MS Treatment
Genzyme’s Lemtrada is the latest medication to be approved by the FDA as a treatment plan for multiple sclerosis under a restricted distribution program. The…
Genzyme’s Lemtrada is the latest medication to be approved by the FDA as a treatment plan for multiple sclerosis under a restricted distribution program. The…
In late December the FDA denied the immediately approval of the new MS treatment drug, Lemtrada, due to the design flaw of not including a…